Pre-cancerous lesions for colorectal cancers in rodents: A new concept

Carcinogenesis

Volumn 24, Issue 6, 2003, Pages 1015-1019

  Yamada, Yasuhiro ^a   Mori, Hideki ^a  

^a GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN;

ARTICLE; CANCER STAGING; CANCER SUSCEPTIBILITY; COLON CARCINOGENESIS; COLON MUCOSA; COLORECTAL CANCER; DYSPLASIA; GENE MUTATION; INTESTINE CRYPT; MOUSE; NONHUMAN; PRECANCER; PRIORITY JOURNAL; RAT; RODENT;

EID: 0038687766     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/bgg041     Document Type: Article

References (48)

1. Vogelstein,B., Fearon,E., Hamilton,S., Kern,S., Preisinger,A., Leppert,M., Nakamura,Y., White,R., Smits,A. and Bos,J. (1988) Genetic alterations during colorectal-tumor development. N. Engl. J. Med., 319, 525-532.
2. Fearon,E. and Vogelstein,B. (1990) A genetic model for colorectal. tumorigenesis. Cell, 61, 759-767.
3. Powell,S., Zilz,N., Beazer-Barclay,Y., Bryan,T., Hamilton,S., Thibodeau,S., Vogelstein,B. and Kinzler,K. (1992) APC mutations occur early during colorectal tumorigenesis. Nature, 359, 235-237.
4. Morin,P., Sparks,A., Korinek,V., Barker,N., Clevers,H., Vogelstein,B. and Kinzler,K. (1997) Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC. Science, 275, 1787-1790.
5. Bird,R. (1995) Role of aberrant crypt foci in understanding the pathogenesis of colon cancer. Cancer Lett., 93, 55-71.
6. Bird,R., McLellan,E. and Bruce,W. (1989) Aberrant crypts, putative precancerous lesions, in the study of the role of diet in the aetiology of colon cancer. Cancer Surv., 8, 189-200.
7. Reddy,B., Rao,C. and Seibert,K. (1996) Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis. Cancer Res., 56, 4566-4569.
8. Zheng,Y., Kramer,P., Lubet,R., Steele,V., Kelloff,G. and Pereira,M. (1999) Effect of retinoids on AOM-induced colon cancer in rats: modulation of cell proliferation, apoptosis and aberrant crypt foci. Carcinogenesis, 20, 255-260.
9. Rao,C., Wang,C., Simi,B., Lubet,R., Kelloff,G., Steele,V. and Reddy,B. (1997) Enhancement of experimental colon cancer by genistein. Cancer Res., 57, 3717-3722.
10. Riggleman,B., Schedl,P. and Wieschaus,E. (1990) Spatial expression of the Drosophila segment polarity gene armadillo is posttranscriptionally regulated by wingless. Cell, 63, 549-560.
11. Behrens,J., Jerchow,B., Wurtele,M., Grimm,J., Asbrand,C., Wirtz,R., Kuhl,M., Wedlich,D. and Birchmeier,W. (1998) Functional interaction of an axin homolog, conductin, with β-catenin, APC and GSK3β. Science, 280, 596-599.
12. Kishida,S., Yamamoto,H., Ikeda,S., Kishida,M., Sakamoto,I., Koyama,S. and Kikuchi,A. (1998) Axin, a negative regulator of the wnt signaling pathway, directly interacts with adenomatous polyposis coli and regulates the stabilization of β-catenin. J. Biol. Chem., 273, 10823-10826.
13. Hart,M., Concordet,J.P., Lassot,I. et al. (1999) The F-box protein beta-TrCP associates with phosphorylated β-catenin and regulates its activity in the cell. Curr. Biol., 9, 207-210.
14. Aberle,H., Bauer,A., Stappert,J., Kispert,A. and Kemler,R. (1997) β-Catenin is a target for the ubiquitin-proteasome pathway. EMBO J., 16, 3797-3804.
15. Korinek,V., Barker,N., Morin,P., Wichen,D.v., Weger,R.d., Kinzler,K., Vogelstein,B. and Clevers,H. (1997) Constitutive transcriptional activation by a β-catenin-Tcf complex in APC-/- colon carcinoma. Science, 275, 1784-1787.
16. He,T., Sparks,A., Rago,C., Hermeking,H., Zawel,L., Costa,L.d., Morin,P., Vogelstein,B. and Kinzler,K. (1998) Identification of c-MYC as a target of the APC pathway. Science, 281, 1509-1512.
17. Tetsu,O. and McCormick,F. (1999) β-Catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature, 398, 422-426.
18. Vogelstein,B. and Kinzler,K. (1998) The Genetic Basis of Human Cancer. McGraw-Hill, New York.
19. Takahashi,M., Fukuda,K., Sugimura,T. and Wakabayashi,K. (1998) β-Catenin is frequently mutated and demonstrates altered cellular location in azoxymethane-induced rat colon tumors. Cancer Res., 58, 42-46.
20. Brabletz,T., Herrmann,K., Jung,A., Faller,G. and Kirchner,T. (2000) Expression of nuclear Β-catenin and c-myc is correlated with tumor size but not with proliferative activity of colorectal adenomas. Am. J. Pathol., 156, 865-870.
21. Yamada,Y., Yoshimi,N., Hirose,Y., Kawabata,K., Matsunaga,K., Shimizu,M., Hara,A. and Mori,H. (2000) Frequent β-catenin gene mutations and accumulations of the protein in the putative preneoplastic lesions lacking macroscopic aberrant crypt foci appearance, in rat colon carcinogenesis. Cancer Res., 60, 3323-3327.
22. Yamada,Y., Yoshimi,N., Hirose,Y. and Mori,H. (2001) Sequential analysis of morphological and biological properties of β-catenin-accumulated crypts, provable preneoplastic lesions independent of aberrant crypt foci in rat colon carcinogenesis. Cancer Res., 61, 1874-1878.
23. Erlandsen,S., Parsons,J. and Taylor,T. (1974) Ultrastructural immunocytochemical localization of lysozyme in the Paneth cells of man. J. Histochem. Cytochem., 22, 401-413.
24. Tan,X., Hsueh,W. and Gonzalez-Crussi,F. (1993) Cellular localization of tumor necrosis factor (TNF)-alpha transcripts in normal bowel and in necrotizing enterocolitis. TNF gene expression by Paneth cells, intestinal eosinophils and macrophages. Am. J. Pathol., 142, 1858-1865.
25. Sauvage,F.d., Keshav,S., Kuang,W., Gillett,N., Henzel,W. and Goeddel,D. (1992) Precursor structure, expression and tissue distribution of human guanylin. Proc. Natl Acad. Sci. USA, 89, 9089-9093.
26. Poulsen,S., Nexo,E., Olsen,P., Hess,J. and Kirkegaard,P. (1986) Immunohistochemical localization of epidermal growth factor in rat and man. Histochemistry, 85, 389-394.
27. Wilson,C., Heppner,K., Rudolph,L. and Matrisian,L. (1995) The metalloproteinase matrilysin is preferentially expressed by epithelial cells in a tissue-restricted pattern in the mouse. Mol. Biol. Cell., 6, 851-869.
28. Wilson,C.L., Heppner,K.J., Labosky,P.A., Hogan,B.L. and Matrisian,L.M. (1997) Intestinal tumorigenesis is suppressed in mice lacking the metalloproteinase matrilysin. Proc. Natl Acad. Sci. USA, 94, 1402-1407.
29. Yamada,Y., Oyama,T., Hirose,Y., Hara,A., Sugie,S., Yoshida,K., Yoshimi,N. and Mori,H. (2003) β-Catenin mutation is selected during malignant transformation in colon carcinogenesis. Carcinogenesis, 24, 91-97.
30. Jen,J., Powell,S.M., Papadopoulos,N., Smith,K.J., Hamilton,S.R., Vogelstein,B. and Kinzler,K.W. (1994) Molecular determinants of dysplasia in colorectal lesions. Cancer Res., 54, 5523-5526.
31. Pretlow,T.P., Brasitus,T.A., Fulton,N.C., Cheyer,C. and Kaplan,E.L. (1993) K-ras mutations in putative preneoplastic lesions in human colon. J. Natl Cancer Inst., 85, 2004-2007.
32. Johnson,L., Mercer,K., Greenbaum,D., Bronson,R.T., Crowley,D., Tuveson,D.A. and Jacks,T. (2001) Somatic activation of the K-ras oncogene causes early onset lung cancer in mice. Nature, 410, 1111-1116.
33. Orford,K., Crockett,C., Jensen,J., Weissman,A. and Byers,S. (1997) Serine phosphorylation-regulated ubiquitination and degradation of β-catenin. J. Biol. Chem., 272, 24735-24738.
34. Moser,A.R., Pitot,H.C. and Dove,W.F. (1990) A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science, 247, 322-324.
35. Su,L.K., Kinzler,K.W., Vogelstein,B., Preisinger,A.C., Moser,A.R., Luongo,C., Gould,K.A. and Dove,W.F. (1992) Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science, 256, 668-670.
36. Rao,C.V., Cooma,I., Rodriguez,J.G., Simi,B., El-Bayoumy,K. and Reddy,B.S. (2000) Chemoprevention of familial adenomatous polyposis development in the APC (min) mouse model by 1,4-phenylene bis(methylene)selenocyanate. Carcinogenesis, 21, 617-621.
37. Min/+ mice. Cancer Res., 62, 6367-6370.
38. Knudson,A.G. Jr. (1971) Mutation and cancer: statistical study of retinoblastoma. Proc. Natl Acad. Sci. USA, 68, 820-823.
39. Shibata,H., Toyama,K., Shioya,H. et al. (1997) Rapid colorectal adenoma formation initiated by conditional targeting of the Apc gene. Science, 278, 120-123.
40. Paulsen,J.E., Steffensen,I.L., Loberg,E.M., Husoy,T., Namork,E. and Alexander,J. (2001) Qualitative and quantitative relationship between dysplastic aberrant crypt foci and tumorigenesis in the Min/+ mouse colon. Cancer Res., 61, 5010-5015.
41. Hirose,Y., Kuno,T., Yamada,Y., Sakata,K., Katayama,M., Yoshida,K., Qiao,Z., Hata,K., Yoshimi,N. and Mori,H. (2003) Azoxymethane-induced beta-catenin-accumulated crypts in colonic mucosa of rodents as an intermediate biomarker for colon carcinogenesis. Carcinogenesis, 24, 107-111.
42. Pretlow,T., Barrow,B., Ashton,W., O'Riordan,M., Pretlow,T., Jurcisek,J. and Stellato,J. (1991) Aberrant crypts: putative preneoplastic foci in human colonic mucosa. Cancer Res., 51, 1564-1567.
43. Pretlow,T.P. and Bird,R.P. (2001) Correspondence re: Y. Yamada et al., Frequent β-catenin gene mutations and accumulations of the protein in the putative preneoplastic lesions lacking macroscopic aberrant crypt foci appearance, in rat colon carcinogenesis. Cancer Res., 60: 3323-3327, 2000; and sequential analysis of morphological and biological properties of β-catenin-accumulated crypts, provable premalignant lesions independent of aberrant crypt foci in rat colon carcinogenesis. Cancer Res., 61: 1874-1878, 2001. Cancer Res., 61, 7699-7701.
44. Hao,X.P., Pretlow,T.G., Rao,J.S. and Pretlow,T.P. (2001) β-Catenin expression is altered in human colonic aberrant crypt foci. Cancer Res., 61, 8085-8088.
45. van de Wetering,M., Sancho,E., Verweij,C. et al. (2002) The β-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell, 111, 241-250.
46. Kudo,S., Hirota,S., Nakajima,T., Hosobe,S., Kusaka,H., Kobayashi,J., Himori,M. and Yagyuu,A. (1994) Colorectal tumours and pit pattern. J. Clin. Pathol., 47, 880-885.
47. Kudo,S., Rubio,C.A., Teixeira,C.R., Kashida,H. and Kogure,E. (2001) Pit pattern in colorectal neoplasia: endoscopic magnifying view. Endoscopy, 33, 367-373.
48. Hamilton,S. and Aaltonen,L. (2000) Tumors of Digestive System. IARC Scientific Press, IARC, Lyon.